• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ZLD 0.00% 68.0¢

ZELIRA THERAPEUTICS LIMITED

Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company... Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription [Rx] business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter [OTC] products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ZLD 30/04/24 2 665
30/04/24 Last post  gregwallis Comments Created with Sketch.  2  Views Created with Sketch.  665 
ZLD 29/04/24 0 233
29/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  233 
ZLD 24/04/24 6 2.9K
Metals & Mining SECTOR NEWS

HOT OFF THE PRESS: World Leading Recoveries Confirmed at Ema Project

BCM
07 May 2024
BRAZILIAN CRITICAL MINERALS LIMITED
24/04/24 Last post  cue Comments Created with Sketch.  6  Views Created with Sketch.  2.9K 
ZLD 16/04/24 2 785
16/04/24 Last post  Viper_00 Comments Created with Sketch.  2  Views Created with Sketch.  785 
ZLD
Summary
03/04/24 37 18K
03/04/24 Last post  FiSaver Comments Created with Sketch.  37  Views Created with Sketch.  18K 
ZLD 23/02/24 9 2.7K
23/02/24 Last post  cue Comments Created with Sketch.  9  Views Created with Sketch.  2.7K 
ZLD
News: ZLD Zelira Therapeutics Says HY Net Loss Attributable A$34.1 Million Versus Loss A$3.3...
22/02/24 0 221
22/02/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  221 
ZLD 31/01/24 1 577
31/01/24 Last post  PutUsernameHere Comments Created with Sketch.  1  Views Created with Sketch.  577 

See All Discussions arrow Created with Sketch.

Timeline

Appendix 4C Cash Flow Report
29 Apr 17:10
 
March 2024 Quarterly Activities Report
29 Apr 17:09
 
Zelira receives $919,000 R&D Tax Incentive Scheme Refund
15 Apr 11:16
 
Appendix 4D & FY24 Interim Financial Report
22 Feb 16:57
 
Appendix 4C Cash Flow Report
31 Jan 12:14
 
December 2023 Quarterly Activities Report
31 Jan 12:13
 
View More arrow Created with Sketch.
(20min delay)
Last
68.0¢
Change
0.000(0.00%)
Mkt cap ! $7.716M
Open High Low Value Volume
68.0¢ 68.0¢ 68.0¢ $11.19K 16.46K

Buyers (Bids)

No. Vol. Price($)
5 12466 68.0¢
 

Sellers (Offers)

Price($) Vol. No.
69.0¢ 372 2
View Market Depth
Last trade - 15.11pm 07/05/2024 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.